This issue of Surgical Oncology Clinics of North America, Guest Edited by John M. Kane III, MD, is devoted to Sarcomas. Articles in this issue include: Prognostic Factors and Staging for Soft Tissue Sarcomas; Margin Status and Local Recurrence: Correlation or Causation?; Systemic Chemotherapy in the Adjuvant and Clinical Metastatic Setting; Pulmonary Metastasectomy; Regional Therapy for Advanced Extremity Sarcomas; Current Approaches to Retroperitoneal Sarcomas; Updates on the Management of Gastrointestinal Stromal Tumors (GIST); Soft Tissue Sarcoma: Immunologic Implications; Atypical Lipomatous Tumor/Well Differentiated Liposarcoma: What is it?; Modern Surgical Therapy: Limb Salvage and the Role of Amputation; Adjuvant Radiation Therapy: and Preoperative, Postoperative, or Not at All.
Management of Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma Aimee M. Crago, MD, PhD, FSSO a,*, ... Surgical Oncology, Department of Surgery, Sarcoma Disease Team, Winship Cancer Institute, Emory University Hospital Midtown, ...
In 2021, more than 13,400 new soft tissue sarcomas will be diagnosed. This issue provides a timely update for management of the most common sarcomas, including discussions of pathology, imaging, chemotherapy, radiation, and reconstruction.
unresectable gastric cancer liver metastases, with an overall response rate of 55.6% and a median OS of 10.5 months. Seki and colleagues46 also analyzed the efficacy of HAI-FEM as a second-line therapy, after the failure of systemic S-1 ...
Indeed, in a study assessing the gender of au- thors across 114 oncology randomized control trials, only 22.9% were ... senior author.59 The highest rate of female senior author sites was seen in breast and head and neck cancer trials.
In 2021, more than 13,400 new soft tissue sarcomas will be diagnosed. This issue provides a timely update for management of the most common sarcomas, including discussions of pathology, imaging, chemotherapy, radiation, and reconstruction.
HEMATOLOGY/ONCOLOGY. CLINICS. OF. NORTH. AMERICA. FORTHCOMING ISSUES RECENT ISSUES April 2020 Myelodysplastic Syndromes ... Editor October 2019 Transfusion Medicine Eric A. Gehrie and Edward L. Snyder, Editors August 2019 Non-Hodgkin's ...
603 Updates in Staging and Management of Malignant Pleural Mesothelioma Andrea S. Wolf and Raja M. Flores While without treatment, malignant pleural mesothelioma (MPM) confers poor survival, cancer-directed surgery as part of ...
Bean J, Brennan C, Shih JY, et al. MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib. Proc Natl Acad Sci U S A 2007;104(52):20932–7.
Wolff AC, Hammond ME, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 2007; ...
Surgical management of wild-type gastrointestinal stromal tumors: a report from the National Institutes of Health pediatric and wildtype GIST clinic. J Clin Oncol 2017;35(5):523–8. 27. Agaram NP, Laquaglia MP, Ustun B, et al.